Filtros

Buscador
Año
Alcaraz MJ, Alcaraz A, Teruel-Montoya R, Campillo JA, de la Torre A, Munoz A, Tomas C, Puche G, Baguena C, Cano A, Minguela A, Bernal E. Subclinical atherosclerosis and immune activation in young HIV-infected patients with telomere shortening. Aging (Albany NY). 2021 Jul 26;13(14):18094-18105. doi: 10.18632/aging.203350. Epub 2021 Jul 26. PubMed PMID: 34310343; PubMed Central PMCID: PMC8351718.
AÑO: 2021; IF: 5.955
Bernal E, Gimeno L, Alcaraz MJ, Quadeer AA, Moreno M, Martinez-Sanchez MV, Campillo JA, Gomez JM, Pelaez A, Garcia E, Herranz M, Hernandez-Olivo M, Martinez-Alfaro E, Alcaraz A, Munoz A, Cano A, McKay MR, Muro M, Minguela A. Activating Killer-Cell Immunoglobulin-Like Receptors Are Associated With the Severity of Coronavirus Disease 2019. J Infect Dis. 2021 Jul 15;224(2):229-240. doi: 10.1093/infdis/jiab228. PubMed PMID: 33928374; PubMed Central PMCID: PMC8135764.
AÑO: 2021; IF: 7.759
Minguela A, Salido EJ, Soto-Ramirez MF, Olga MA, Leal JD, Garcia-Garay MC, Periago A, Berenguer M, Blanque M, Campillo JA. Low-affinity immunoglobulin gamma Fc region receptor III-B (FcgammaRIIIB, CD16B) deficiency in patients with blood and immune system disorders. Br J Haematol. 2021 Dec;195(5):743-747. doi: 10.1111/bjh.17828. Epub 2021 Sep 20. PubMed PMID: 34544201.
AÑO: 2021; IF: 8.615
Vasco-Mogorron MA, Campillo JA, Periago A, Cabanas V, Berenguer M, Garcia-Garay MC, Gimeno L, Soto-Ramirez MF, Martinez-Hernandez MD, Muro M, Minguela A. Proliferation to Apoptosis Tumor Cell Ratio as a Biomarker to Improve Clinical Management of Pre-Malignant and Symptomatic Plasma Cell Neoplasms. Int J Mol Sci. 2021 Apr 9;22(8):3895. doi: 10.3390/ijms22083895. PubMed PMID: 33918790; PubMed Central PMCID: PMC8068942.
AÑO: 2021; IF: 6.208
Gimeno L, Gonzalez-Lozano I, Soto-Ramirez MF, Martinez-Sanchez MV, Lopez-Cubillana P, Fuster JL, Martinez-Garcia J, Martinez-Escribano J, Campillo JA, Pons-Fuster E, Ferri B, Lopez-Abad A, Muro M, Minguela A. CD8+ T lymphocytes are sensitive to NKG2A/HLA-E licensing interaction: role in the survival of cancer patients. Oncoimmunology. 2021 Oct 14;10(1):1986943. doi: 10.1080/2162402X.2021.1986943. eCollection 2021. PubMed PMID: 34676148; PubMed Central PMCID: PMC8525952.
AÑO: 2021; IF: 7.723